Live Bending Spoons Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

GRI BIO, Inc.

GRI

Latest SEC Filings from GRI BIO, Inc.

  1. 1
    1

    GRI Bio Reports Q2 2026 Financial Results with Reduced Net Loss and Increased Cash Reserves

    via official filing (AI summary) 2 months ago 0 comments
  2. 2
    1

    GRI Bio Reports Q1 2026 Financial Results with Reduced Net Loss and Increased Cash Reserves

    via official filing (AI summary) 5 months ago 0 comments
  3. 3
    1

    GRI Bio Reports Increased Net Loss and Progress in Clinical Trials for GRI-0621

    via official filing (AI summary) 9 months ago 0 comments
  4. 4
    1

    GRI Bio Reports $3.4 Million Net Loss in Q3 2025, Faces Financial Challenges

    via official filing (AI summary) 11 months ago 0 comments
  5. 5
    1

    GRI Bio Reports $2.9 Million Net Loss in Q2 2025, Focuses on Clinical Development

    via official filing (AI summary) about 1 year ago 0 comments
  6. 6
    1

    GRI Bio Reports $3 Million Net Loss in Q1 2025, Increases R&D Spending

    via official filing (AI summary) over 1 year ago 0 comments
  7. 7
    1

    GRI Bio Reports $8.2 Million Net Loss for Fiscal Year 2024, Advances Product Candidates

    via official filing (AI summary) over 1 year ago 0 comments
  8. 8
    1

    GRI Bio Reports Financial Results for Third Quarter 2024, Narrows Net Loss and Reduces Operating Expenses

    via official filing (AI summary) almost 2 years ago 0 comments